Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
about
A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytesA mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathyPlasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cellsThe receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexesDistribution of the human intracellular serpin protease inhibitor 8 in human tissuesPlasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular formsFacultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2Oxygen as a regulator of cellular phenotypes in pregnancy and cancer.A two-step recognition of signal sequences determines the translocation efficiency of proteins.Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos.Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils.Regulation of plasminogen activator production by endothelial cells: role in fibrinolysis and local proteolysis.Coupled translocation events generate topological heterogeneity at the endoplasmic reticulum membrane.Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.The plasmin-antiplasmin system: structural and functional aspects.The role of proteasome beta subunits in gastrin-mediated transcription of plasminogen activator inhibitor-2 and regenerating protein1Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1.Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response.Tumor necrosis factor alpha up-regulates in an autocrine manner the synthesis of plasminogen activator inhibitor type-1 during induction of monocytic differentiation of human HL-60 leukemia cells.Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.Proteinase inhibitor 6 cannot be secreted, which suggests it is a new type of cellular serpin.Modulation of proteolytic activity during neuritogenesis in the PC12 nerve cell: differential control of plasminogen activator and plasminogen activator inhibitor activities by nerve growth factor and dibutyryl-cyclic AMP.Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes.Alcohol-induced up-regulation of fibrinolytic activity and plasminogen activators in human monocytes.Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes.SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs.High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.
P2860
Q24319054-C393A563-D924-48C4-AB0D-F017C6539D90Q24564566-8B2913C3-C809-4383-8651-4A6431CBA45EQ24612910-486F9B29-3E41-4B1B-BBC3-F656BAB03BE2Q24678932-70F121C4-0894-446B-9C39-A3A00EE9FD07Q28213636-C49E03EA-F0CD-42FD-BF04-0BDD8D32A59BQ28285553-A5652435-B5CF-444B-965F-2071D219BAEDQ33584270-07FF62C0-4804-4C51-8E84-00A3FA65726BQ34122203-8E6CC9D9-01C2-42BA-BCB0-300155CA6826Q35843984-D0ABFFD7-5E70-471D-83B1-A4D11DDD2E52Q36218668-A3AACA05-332B-4D28-B481-315C9C1C30F5Q36221987-DFA27D04-4BDA-4889-B752-C1DF1FA56C95Q36355159-2C452F1D-522B-44EE-A34E-76E7FB376572Q36356179-C00CD50D-FFEF-4CF7-9122-F3E2488F8512Q36670521-929BD0EB-38F1-47E8-AE73-1FC458105299Q36910362-DFCF1A49-F534-472C-92B1-55A1FEC3B757Q37424686-8509A590-EF7C-4C5E-A9C6-3ABA66F73DEEQ37817023-D1E5A5CD-35D9-44F8-9259-55819B0BE048Q39173170-3F139CEE-8E2F-4EFF-A588-B9F2704AFB8FQ39508019-64C0765F-04D3-4F31-93B4-3A25675387DDQ39906230-7B7216E6-4590-4350-AD4C-EF43211C1B44Q40249142-D7753F19-C3C8-40EA-9504-D2B624E507FBQ40903271-D25EC2EA-159F-42A7-84E6-9A606293282CQ41206436-218A0F6B-72C9-4EE7-9B09-39982FE60432Q41237919-39264837-D1E3-4545-B1D9-CF1C5F2077EBQ41673525-FB920B86-70B8-415E-8677-4131FD0C5C80Q42481882-55BA905D-A699-448E-9226-E58F2FEAFB64Q44116447-6398A564-241A-4C84-895E-B17686415452Q47950786-79D26218-AF02-48BC-9682-EB069269A61AQ50960691-E2B4A1A1-CFEA-42E2-AFC5-8FA127B5628EQ53318958-5684B5A7-DDB3-4848-83E4-27731AD24A2F
P2860
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@ast
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@en
type
label
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@ast
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@en
prefLabel
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@ast
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@en
P2093
P2860
P356
P1476
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages.
@en
P2093
P2860
P304
P356
10.1084/JEM.165.2.320
P407
P577
1987-02-01T00:00:00Z